Uniting India slide
Photos of Review cover
Photo of pills
Purple ribbon promoting awareness about gender based violence

ID Clinical Minute is now available for Continuing Medical Education Credit!

"The Indo-US clinical research & education partnership started with a single NIH grant to study maternal-infant HIV transmission." Now with 76 studies underway, this short film chronicles the history & impact of our work in India. 

What a year! Our 2017 Year In Review outlines the most ambitious 365 days we’ve had to date.

Lancet Global Health: This letter by Dr. Sachin Atre outlines factors that complicate pharmaceutical regulation in India, which is a component of WHO's Global Antimicrobial Resistance Action Plan.

BMC Womens Health: In our study, 23% of women reported experiencing gender based violence, and 90% reported they had never been asked about it in the healthcare setting. 

A 19 year old college-attending man presented with: Moderate grade fever with chills X  7-10 days,
Altered sensorium since morning, No H/...

Needle and vial of vaccine

Dr. Vidya Mave is leading this clinical trial evaluating the safety and efficacy of a new recombinant BCG vaccine.

Secondhand smoke

Pediatrics: Dr. Jessica Elf and colleagues evaluated the validity of standard self-reported measures for secondhand smoke (SHS)...

The Most Innovative Companies list recognizes pioneering companies across 36 categories, from health to artificial intelligence to wellness.

Photo of  Dr. Bob Bollinger

CCGHE Director Bob Bollinger weighs in on WHO's priority pathogens for 2018.

CCGHE invented the emocha Mobile Health platform, and it's changing the way tuberculosis patients are cared for.

MobiHealthNews Logo

Bob Bollinger interviewed about utility of mobile health in keeping patients connected to care.

CDC logo

emocha's video Directly Observed Therapy is highlighted in this report.

World AIDS Day Organizing Team at BJGMC

150 people participated in a non-communicable diseases awareness camp for people in Pune, India, living with HIV.